Paid Clinical Trials in Florida

Florida has 4,147 paid clinical trials enrolling now across cities including Miami, Tampa and Jacksonville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Florida include Mayo Clinic Jacksonville, Moffitt Cancer Center and University of Miami Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 25, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

3,687 clinical trials

↓ Download CSV

Clinical Trial on Agitation in Alzheimer's Dementia

for Alzheimer Disease

Sites in Miami, Tampa +20 more locations

Sponsor: IGC Pharma, LLC

Sex: All·Age: 60+

Code: NCT05543681·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Sites in St. Petersburg +15 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05416307·Phase 2, Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for Somatostatin Receptor Positive (SSTR+)

Sites in Jacksonville +17 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 100

Code: NCT06784752·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

for Advanced Melanoma

Sites in Hialeah +10 more locations

Sponsor: Eikon Therapeutics

Sex: All·Age: 18+

Code: NCT06697301·Phase 2, Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

Sites in Plantation, Margate +12 more locations

Sponsor: Zenith Epigenetics

Sex: Male·Age: 18+

Code: NCT04986423·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

for Coagulation Disorder

Sites in Gainesville +12 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT05156983·Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for Metastatic Castration-Resistant Prostate Cancer

Sites in Hialeah, Aventura +18 more locations

Sponsor: Kyntra Bio

Sex: Male·Age: 18+

Code: NCT06842498·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

for Chronic Inflammatory Demyelinating Polyneuropathy

Sites in Miami, Tampa +10 more locations

Sponsor: argenx

Sex: All·Age: 18+

Code: NCT06920004·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

for Hyperkalemia

Drug: patiromer

Sites in Miami, Orlando +9 more locations

Sponsor: Vifor Pharma, Inc.

Sex: All·Age: 0 - 11

Code: NCT05766839·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

for Dravet Syndrome

Sites in Miami +10 more locations

Sponsor: Encoded Therapeutics

Sex: All·Age: 6 Months - 17

Code: NCT05419492·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

for Hidradenitis Suppurativa

Drug: Bimekizumab

Sites in Miami +10 more locations

Sponsor: UCB Biopharma SRL

Sex: All·Age: 9 - 17

Code: NCT06921850·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

for Colonic Polyps

Sites in St. Petersburg +10 more locations

Sponsor: Capso Vision, Inc.

Sex: All·Age: 45 - 75

Code: NCT07089615·Recruiting·Listed Jul 2025

Apply to this trial

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for Urothelial Carcinoma Bladder

Sites in Miami, Orlando +10 more locations

Sponsor: Aktis Oncology, Inc.

Sex: All·Age: 18+

Code: NCT07020117·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

for Ovarian Cancer

Drug: Relacorilant

Sites in Fort Myers, West Palm Beach +14 more locations

Sponsor: Corcept Therapeutics

Sex: Female·Age: 18+

Code: NCT06906341·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

for Migraine

Sites in Tampa, Hialeah +12 more locations

Sponsor: H. Lundbeck A/S

Sex: All·Age: 6 - 17

Code: NCT05164172·Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

Study of Olutasidenib and Temozolomide in HGG

for High Grade Glioma

Sites in Miami +10 more locations

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 12 - 39

Code: NCT06161974·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for Myelodysplastic Syndromes

Sites in Miami, Tampa +21 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06499285·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for Familial Adenomatous Polyposis (FAP)

Sites in Orlando, Weston +16 more locations

Sponsor: Rapamycin Holdings Inc.

Sex: All·Age: 18+

Code: NCT06950385·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for Migraine

Sites in Miami, Tampa +11 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 70

Code: NCT06602479·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for PDAC

Sites in Jacksonville +17 more locations

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

Sites in Sarasota +8 more locations

Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06752681·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Jacksonville +13 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 12+

Code: NCT04855656·Phase 1·Recruiting·Listed Apr 2021

Apply to this trial

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

for Noonan Syndrome

Drug: Vosoritide

Sites in Miami +21 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: 3 - 11

Code: NCT06668805·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for Locally Advanced Solid Tumor

Sites in Miami +19 more locations

Sponsor: Nuvalent Inc.

Sex: All·Age: 12+

Code: NCT05384626·Phase 1, Phase 2·Recruiting·Listed May 2022

Apply to this trial

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

for Systemic Sclerosis

Sites in Jacksonville +9 more locations

Sponsor: Cabaletta Bio

Sex: All·Age: 18 - 75

Code: NCT06328777·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

for Idiopathic Hypersomnia

Sites in Winter Park, Brandon +11 more locations

Sponsor: Takeda

Sex: All·Age: 18 - 70

Code: NCT06812078·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

for Multiple System Atrophy

Sites in Tampa +14 more locations

Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All·Age: 30 - 75

Code: NCT06568237·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for Focal Segmental Glomerulosclerosis

Drug: Brivekimig

Sites in Tampa +15 more locations

Sponsor: Sanofi

Sex: All·Age: 16 - 75

Code: NCT06500702·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

for Hepatocellular Carcinoma (HCC)

Drug: Ipilimumab

Sites in Jacksonville, Plantation +9 more locations

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18 - 65

Code: NCT07176650·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for Myelofibrosis

Sites in Miami, Tampa +21 more locations

Sponsor: Disc Medicine, Inc

Sex: All·Age: 18+

Code: NCT05320198·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for Adult Acute Myeloid Leukemia

Sites in Tampa +12 more locations

Sponsor: Priothera SAS

Sex: All·Age: 18 - 75

Code: NCT05429632·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

Fertilo In Vitro Research Study and Trial

for In Vitro Maturation of Oocytes

Sites in Clearwater, Pembroke Pines +11 more locations

Sponsor: Gameto, Inc.

Sex: Female·Age: 18 - 35·Accepts healthy volunteers

Code: NCT06858111·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Orlando +13 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 12+

Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

for Lymphatic Malformations

Sites in Jacksonville +17 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 0 - 100

Code: NCT05948943·Phase 2, Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

for C3G

Drug: Iptacopan

Sites in Miami +4 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 60

Code: NCT04817618·Phase 3·Recruiting·Listed Mar 2021

Apply to this trial

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for Major Depressive Disorder

Drug: NBI-1065845

Sites in Miami, Maitland +8 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18+

Code: NCT06963021·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

for Diffuse Cutaneous Systemic Sclerosis

Drug: Ianalumab

Sites in Sarasota, Plantation +15 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 70

Code: NCT06470048·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

for Multiple Myeloma

Drug: Daratumumab

Sites in Jupiter +9 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT05623020·Phase 3·Recruiting·Listed Nov 2022

Apply to this trial

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

for Scleroderma, Diffuse

Sites in Zephyrhills +13 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 70

Code: NCT06655896·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

for Regional Citrate Anticoagulation (RCA)

Sites in Miami +7 more locations

Sponsor: Vantive Health LLC

Sex: All·Age: 18+

Code: NCT05399537·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial